analiza aiqbench
This partnership marks a significant milestone for Quantum Computing Inc., transitioning its Dirac-3S quantum optimization machine from theoretical potential to practical application in pharmaceutical R&D. By leveraging quantum algorithms to analyze complex clinical datasets for Alzheimer's and rare diseases, the collaboration aims to identify novel treatment indications and biomarkers more efficiently than conventional statistical or machine-learning methods. This move validates the utility of quantum computing in solving high-dimensional scientific problems within the biotech sector.
Quantum Computing Inc expands into pharma with INmune Bio deal

INmune Bio & Quantum Computing Inc. are partnering to apply quantum optimization, AI, & data analytics to Alzheimer’s drug XPro.
INmune Bio and Quantum Computing Inc. are combining clinical data from four trials with QCi’s Dirac-3S quantum optimization machine to explore new uses for XPro1595, an investigational Alzheimer’s treatment. This collaboration marks QCi’s first commercial customer within the pharmaceutical and…
Extras afișat conform termenilor RSS ai publicației · 40 cuvinte · textul integral și figurile sunt pe site-ul publicației
Subiecte conexe

Stock Market Today Highlights, Sept 2: Sensex ends 373 pts lower at 76, 570, Nifty below 24, 000; Asian Paints, HDFC Bank fall most
thehindubusinessline.com · 2 sept. 2026

Top Quantum Error Correction Companies 2026: Complete Vendor Guide
Quantum Zeitgeist · 30 mai 2026

Forbes Asia 100 To Watch 2026
forbes.com · 24 aug. 2026
News Archive 2026
Quantum Computing Report · 25 iul. 2026